PMDA drug package insert
リルゾール錠50mg「AA」
PMDA Prescription drug · ダイト株式会社 · package insert Oct 17, 2024
Key facts
| Brand names | リルゾール錠50mg「AA」 |
|---|---|
| Nonproprietary names | リルゾール |
| Companies | 製造販売元／ダイト株式会社, 発売元／あすか製薬株式会社, 販売元／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 筋萎縮性側索硬化症用剤 |
| Therapeutic category codes | 87119 |
| YJ codes | 1190011F1030 |
| Approval numbers | 22500AMX01505 |
| Package insert edition | 第1版 |
| Package insert date | Oct 17, 2024 |
| PMDA document key | 400073_1190011F1030_1 |
| PMDA company code | 400073 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: